Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM

被引:185
作者
Mueller, I.
Kordowich, S.
Holzwarth, C.
Spano, C.
Isensee, G.
Staiber, A.
Viebahn, S.
Gieseke, F.
Langer, H.
Gawaz, M. P.
Horwitz, E. M.
Conte, P.
Handgretinger, R.
Dominici, M.
机构
[1] Univ Childrens Hosp, D-72076 Tubingen, Germany
[2] Univ Modena & Reggio Emilia, Dept Hematol & Oncol, Lab Cell Biol & Adv Canc Therapy, Modena, Italy
[3] Univ Clin Internal Med 3, Tubingen, Germany
[4] St Jude Childrens Hosp, Div Stem Cell Transplantat, Memphis, TN 38105 USA
[5] St Jude Childrens Hosp, Div Expt Hematol, Memphis, TN 38105 USA
关键词
FFP; FCS-free culture; multipotent mesenchymal stromal cells; platelets;
D O I
10.1080/14653240600920782
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background Multipotent mesenchymal stromal cells ( MSC) have become important tools in regenerative and transplantation medicine. Rapidly increasing numbers of patients are receiving in vitro-expanded MSC. Culture conditions typically include FSC because human serum does not fully support growth of human MSC in vitro (MSCFCS). Concerns regarding BSE, other infectious complications and host immune reactions have fueled investigation of alternative culture supplements. Methods As PDGF has long been identified as a growth factor for MSC, we tested media supplementation with platelet lysate for support of MSC proliferation. Results We found that primary cultures of BM-derived MSC can be established with animal serum-free media containing fresh frozen plasma and platelets (MSCFFPP). Moreover, MSCFFPP showed vigorous proliferation that was superior to classical culture conditions containing FCS. MSCFFPP morphology was equivalent to MSC FCS, and MSCFFPP expressed CD73, CD90, CD105, CD106, CD146 and HLA-ABC while being negative for CD34, CD45 and surface HLA-DR, as expected. In addition to being phenotypically identical, MSCFFPP could efficiently differentiate into adipocytes and osteoblasts. In terms of immune regulatory properties, MSCFFPP were indistinguishable from MSC FCS. Proliferation of PBMC induced by IL-2 in combination with OKT-3 or by PHA was inhibited in the presence of MSCFFPP. Discussion Taken together, FCS can be replaced safely by FFPP in cultures of MSC for clinical purposes.
引用
收藏
页码:437 / 444
页数:8
相关论文
共 27 条
  • [1] Mesenchymal stem cells: clinical applications and biological characterization
    Barry, FP
    Murphy, JM
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (04) : 568 - 584
  • [2] Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells
    Burns, JS
    Abdallah, BM
    Guldberg, P
    Rygaard, J
    Schroder, HD
    Kassem, M
    [J]. CANCER RESEARCH, 2005, 65 (08) : 3126 - 3135
  • [3] Mesenchymal stem cells: Biology and potential clinical uses
    Deans, RJ
    Moseley, AB
    [J]. EXPERIMENTAL HEMATOLOGY, 2000, 28 (08) : 875 - 884
  • [4] Mesenchymal stem cells and hematopoietic stem cell transplantation
    Fibbe, WE
    Noort, WA
    [J]. HEMATOPOIETIC STEM CELLS 2002: GENETICS AND FUNCTION, 2003, 996 : 235 - 244
  • [5] Host origin of marrow mesenchymal stem cells following allogeneic cord-blood stem-cell transplantation
    Hongeng, S
    Petvises, S
    Rerkamnuaychoke, B
    Worapongpaiboon, S
    Tardtong, P
    Apibal, S
    Ungkanont, A
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 74 (02) : 235 - 236
  • [6] Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
    Horwitz, EM
    Gordon, PL
    Koo, WKK
    Marx, JC
    Neel, MD
    McNall, RY
    Muul, L
    Hofmann, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (13) : 8932 - 8937
  • [7] Engineering mesenchymal stem cells for immunotherapy
    Jorgensen, C
    Djouad, F
    Apparailly, F
    Noël, D
    [J]. GENE THERAPY, 2003, 10 (10) : 928 - 931
  • [8] Nonhematopoletic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction
    Kawada, H
    Fujita, J
    Kinjo, K
    Matsuzaki, Y
    Tsuma, M
    Miyatake, H
    Muguruma, Y
    Tsuboi, K
    Itabashi, Y
    Ikeda, Y
    Ogawa, S
    Okano, H
    Hotta, T
    Ando, K
    Fukuda, K
    [J]. BLOOD, 2004, 104 (12) : 3581 - 3587
  • [9] Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation
    Kim, DW
    Chung, YJ
    Kim, TG
    Kim, YL
    Oh, IH
    [J]. BLOOD, 2004, 103 (05) : 1941 - 1948
  • [10] Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)
    Koç, ON
    Day, J
    Nieder, M
    Gerson, SL
    Lazarus, HM
    Krivit, W
    [J]. BONE MARROW TRANSPLANTATION, 2002, 30 (04) : 215 - 222